Assyro AI

Orange Book product · Generic (ANDA)

TAPENTADOL HYDROCHLORIDE

TAPENTADOL HYDROCHLORIDE

Generic (ANDA)ANDA 219119RX NOVITIUM PHARMA

At a glance

Jan 26, 2026

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 26, 2026

    5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TAPENTADOL HYDROCHLORIDE

Strength

EQ 20MG BASE/ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

ANDA 219119

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of TAPENTADOL HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.